ElevenLabs eyes $22 billion valuation in secondary tender offer

Context and recent developments

On July 2, 2026 Bloomberg reported that ElevenLabs – a voice‑synthesis platform founded in 2022 by Mati Staniszewski and Piotr Dabkowski – has entered preliminary discussions with investors for a secondary tender offer. The proposed transaction would price the company at approximately $22 billion, representing a two‑fold increase over the $11 billion valuation set in the Series D financing completed in February 2026. The tender is expected to close by September 2026.

ElevenLabs’ most recent financing round raised $500 million from a consortium that included Sequoia Capital, Andreessen Horowitz and ICONIQ Capital. In September 2025 the company completed a $100 million employee tender at a $6.6 billion valuation, and it first achieved unicorn status at $1.1 billion in early 2024. The current proposal would therefore constitute a 20‑fold increase in market value within a two‑year span.

Tender structure and mechanics

The offer is a pure secondary share sale. Existing shareholders – principally employees and early investors – would sell a portion of their holdings to new investors. No new capital would flow to ElevenLabs, meaning the company’s balance sheet will remain unchanged. This structure is typical for high‑growth firms that have reached a valuation ceiling but still wish to provide liquidity to early participants without diluting existing owners.

Because the tender is still in the early‑talks stage, final terms such as the exact share percentage being offered, pricing methodology, and eligibility criteria for purchasers have not been disclosed. Bloomberg notes that the process is still “preliminary,” and the company has not affirmed any definitive timeline beyond the September 2026 close date.

Valuation dynamics

The $22 billion figure translates to a valuation multiple of roughly 44‑times the company’s most recent annual recurring revenue (ARR) of $500 million, as reported in May 2026. By contrast, the February 2026 Series D round implied an ARR multiple of about 22‑times. The steep upward shift reflects both market enthusiasm for generative‑AI voice technology and the scarcity of comparable public comps.

ElevenLabs’ client roster – which now includes Deutsche Telekom, Boston Consulting Group and Revolut – underscores its penetration into enterprise‑grade use cases. However, the valuation also incorporates expectations of future product expansion, cross‑sell opportunities within the financial services sector, and the broader AI‑driven content creation market.

Revenue multiple implications

A 44‑times ARR multiple places ElevenLabs among the most heavily premium‑valued AI companies in the pre‑IPO space. Historically, such multiples have been justified when a firm demonstrates defensible technology, high‑growth margins, and a clear path to scaling beyond a niche market.

In ElevenLabs’ case, the ARR multiple is supported by a combination of steady top‑line growth (ARR grew from $250 million in early 2025 to $500 million in mid‑2026) and the company’s ability to command premium pricing for its voice‑cloning API. The pricing power is buttressed by its intellectual property and a proprietary dataset that enables high‑fidelity synthesis across multiple languages.

Nevertheless, investors should weigh the multiple against potential headwinds, such as ongoing legal scrutiny of training‑data practices. A class‑action lawsuit under the Illinois Biometric Information Privacy Act (BIPA) raises questions about data provenance and could affect future licensing arrangements.

Implications for the pre‑IPO secondary market

ElevenLabs’ tentative $22 billion tender illustrates a broader trend: secondary markets are becoming a key liquidity mechanism for high‑growth AI firms that have not yet reached an IPO. The demand for exposure to generative‑AI leaders is driving secondary valuations higher, often beyond the pricing of fresh equity rounds.

For investors, secondary tenders offer a way to acquire sizable stakes in companies that are otherwise closed to new capital, while avoiding dilution risk. The trade‑off is the lack of capital infusion to the operating business, meaning any upside must stem from future growth rather than immediate balance‑sheet strengthening.

Moreover, the ElevenLabs case may set a benchmark for other AI firms considering similar liquidity events. Companies with ARR in the $300‑$600 million band are likely to see secondary valuations calibrated against the 40‑plus‑times ARR multiple demonstrated here, subject to comparable legal and competitive dynamics.

Outlook and strategic considerations

Co‑founder Mati Staniszewski has indicated that an IPO could occur within the next two to three years. A successful secondary tender could simplify that pathway by consolidating ownership among institutional investors and reducing the share‑count of employee‑held stock, thereby enhancing market perception of liquidity at the time of listing.

Potential investors should monitor the evolution of the tender’s pricing terms, the proportion of shares being offered, and any regulatory developments related to training‑data usage. While the valuation reflects strong momentum, the ultimate success of the transaction will hinge on the willingness of secondary buyers to absorb the premium and on ElevenLabs’ ability to sustain its revenue growth trajectory.

In sum, the proposed $22 billion secondary tender underscores the increasing sophistication of the pre‑IPO secondary market for AI companies. It offers a tangible case study of how valuation multiples, revenue dynamics, and legal considerations intersect in the pricing of high‑growth, technology‑centric firms.